122 related articles for article (PubMed ID: 38932253)
1. Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine.
Manukyan H; Lal M; Zhu C; Singh O; Lin TL; Tritama E; Chumakov K; Lee SM; Laassri M
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932253
[TBL] [Abstract][Full Text] [Related]
2. Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine.
Manukyan H; Rodionova E; Zagorodnyaya T; Lin TL; Chumakov K; Laassri M
Virol J; 2019 Oct; 16(1):122. PubMed ID: 31660997
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples.
Manukyan H; Tritama E; Wahid R; Anstadt J; Konz J; Chumakov K; Laassri M
Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006061
[TBL] [Abstract][Full Text] [Related]
4. Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
Wahid R; Mercer LD; De Leon T; DeAntonio R; Sáez-Llorens X; Macadam A; Chumakov K; Strating J; Koel B; Konopka-Anstadt JL; Oberste MS; Burns CC; Andino R; Tritama E; Bandyopadhyay AS; Aguirre G; Rüttimann R; Gast C; Konz JO
Lancet Microbe; 2022 Dec; 3(12):e912-e921. PubMed ID: 36332645
[TBL] [Abstract][Full Text] [Related]
5. Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
van Hoorebeke C; Huang C; Leary S; Holubar M; Altamirano J; Halpern MS; Sommer M; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S121-S126. PubMed ID: 30376092
[TBL] [Abstract][Full Text] [Related]
6. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Van Damme P; De Coster I; Bandyopadhyay AS; Revets H; Withanage K; De Smedt P; Suykens L; Oberste MS; Weldon WC; Costa-Clemens SA; Clemens R; Modlin J; Weiner AJ; Macadam AJ; Andino R; Kew OM; Konopka-Anstadt JL; Burns CC; Konz J; Wahid R; Gast C
Lancet; 2019 Jul; 394(10193):148-158. PubMed ID: 31174831
[TBL] [Abstract][Full Text] [Related]
7. Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.
Dimitriou TG; Kyriakopoulou Z; Tsakogiannis D; Fikatas A; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
Virus Genes; 2016 Aug; 52(4):453-62. PubMed ID: 27098645
[TBL] [Abstract][Full Text] [Related]
8. Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
Altamirano J; Leary S; van Hoorebeke C; Sarnquist C; Behl R; García-García L; Ferreyra-Reyes L; Huang C; Sommer M; Maldonado Y
Clin Infect Dis; 2018 Oct; 67(suppl_1):S98-S102. PubMed ID: 30376093
[TBL] [Abstract][Full Text] [Related]
9. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture.
Taniuchi M; Begum S; Uddin MJ; Platts-Mills JA; Liu J; Kirkpatrick BD; Chowdhury AH; Jamil KM; Haque R; Petri WA; Houpt ER
J Clin Microbiol; 2015 Jan; 53(1):206-11. PubMed ID: 25378579
[TBL] [Abstract][Full Text] [Related]
11. Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.
Yeh MT; Smith M; Carlyle S; Konopka-Anstadt JL; Burns CC; Konz J; Andino R; Macadam A
Nature; 2023 Jul; 619(7968):135-142. PubMed ID: 37316671
[TBL] [Abstract][Full Text] [Related]
12. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
Buchheit KH; Daas A; Stalder J
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
[TBL] [Abstract][Full Text] [Related]
13. Multiplex PCR-Based Neutralization (MPBN) Assay for Titers Determination of the Three Types of Anti-Poliovirus Neutralizing-Antibodies.
Manukyan H; Petrovskaya S; Chumakov K; Laassri M
Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32150852
[TBL] [Abstract][Full Text] [Related]
14. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
[TBL] [Abstract][Full Text] [Related]
15. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
16. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
[TBL] [Abstract][Full Text] [Related]
17. Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2.
Manukyan H; Tritama E; Wahid R; Ansari A; Konz J; Chumakov K; Laassri M
Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34201447
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
19. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
Kong J
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
[TBL] [Abstract][Full Text] [Related]
20. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
